Welcome to LookChem.com Sign In|Join Free
  • or
5-Isoxazolecarboxylic acid, 3-(2-pyridinyl)-, also known as 3-(2-Pyridinyl)-5-isoxazolecarboxylic acid, is a chemical compound with the molecular formula C8H5N2O3. It is a white crystalline solid that is soluble in water and various organic solvents. 5-Isoxazolecarboxylic acid, 3-(2-pyridinyl)- is characterized by the presence of an isoxazole ring fused to a pyridine ring, with a carboxylic acid group attached to the isoxazole. It is used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals, particularly those with potential applications in the treatment of neurological disorders and as insecticides. The compound's unique structure and properties make it a valuable building block in the development of new drugs and chemical products.

716362-11-7

Post Buying Request

716362-11-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

716362-11-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 716362-11-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,1,6,3,6 and 2 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 716362-11:
(8*7)+(7*1)+(6*6)+(5*3)+(4*6)+(3*2)+(2*1)+(1*1)=147
147 % 10 = 7
So 716362-11-7 is a valid CAS Registry Number.

716362-11-7Downstream Products

716362-11-7Relevant academic research and scientific papers

5-Substituted pyridylisoxazoles as effective inhibitors of platelet aggregation

Demina,Khodonov,Sinauridze,Shvets,Varfolomeev

, p. 2092 - 2113 (2015/06/08)

A series of 5-substituted 3-pyridylisoxazoles were synthesized using [3+2] cycloaddition of nitrile oxides to alkynes with variation of substituents at position 5 of the isoxazole ring without additional synthetic stages and with retention of 2-pyridyl-, 3-pyridyl, and 4-pyridyl substituents at position 3 of the isoxazole ring. Substituted pyridylisoxazoles are the potential antiaggregatory agents showing in vitro activity in the concentration range from 1?10-6 mol L-1 to 1?10-4 mol L-1 toward the human platelet rich blood plasma with arachidonic acid being used as the inductor of aggregation. These compounds do not act as cyclooxygenase or thromboxane synthase inhibitors, nor as thrombin inhibitors.

Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases

Bryant, Clifford,Kerr, Iain D.,Debnath, Moumita,Ang, Kenny K.H.,Ratnam, Joseline,Ferreira, Rafaela S.,Jaishankar, Priyadarshini,Zhao, DongMei,Arkin, Michelle R.,McKerrow, James H.,Brinen, Linda S.,Renslo, Adam R.

scheme or table, p. 6218 - 6221 (2010/06/19)

We describe here the identification of non-peptidic vinylsulfones that inhibit parasite cysteine proteases in vitro and inhibit the growth of Trypanosoma brucei brucei parasites in culture. A high resolution (1.75 A) co-crystal structure of 8a bound to cruzain reveals how the non-peptidic P2/P3 moiety in such analogs bind the S2 and S3 subsites of the protease, effectively recapitulating important binding interactions present in more traditional peptide-based protease inhibitors and natural substrates.

Concise synthesis and antimicrobial activities of new substituted 5-isoxazolpenicillins

Wang, Xi-Zhao,Jia, Jiong,Zhang, Yan,Xu, Wei-Ren,Liu, Wei,Shi, Fang-Niu,Wang, Jian-Wu

, p. 643 - 652 (2008/03/11)

The synthesis of a series of new 5-isoxazolpenicillins is described, which were obtained by coupling substituted isoxazoles with 6-APA. Concise large-scale synthesis of 3,5-disubstituted isoxazoles by 1,3-dipolar cycloaddition using copper(I) as catalyst was also investigated. Representative compounds were assayed for antimicrobial activities, showing satisfactory antimicrobial activities against Gram-negative bacteria.

Ramoplanin derivatives possessing antibacterial activity

-

Page/Page column 39; 49, (2010/11/23)

Novel ramoplanin derivatives are disclosed. These ramoplanin derivatives exhibit antibacterial activity. As the compounds of the subject invention exhibit potent activities against gram positive bacteria, they are useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 716362-11-7